COLUMBIA, S.C., Nov. 21 /PRNewswire-FirstCall/ -- Collexis Holdings Inc.
(OTC Bulletin Board: CLXS), a leading developer of semantic search and
knowledge discovery software, announced today that Outsell, Inc. has named
Collexis as one of its rising stars. Outsell, the only research and advisory
firm focused on the publishing, information, and education industries,
recognized Collexis for its expert profiling solutions that add value through
data visualization and data processing - technology that is becoming an
important part of information companies' core activities.
Collexis was recognized as one of five rising stars in the scientific,
technical and medical information (STM) market based on its impact on
traditional business practices through its ground-breaking technology.
"We are very pleased to be recognized as a key industry player in
Outsell's 2008 Market Forecast and Trends Report for the STM market," said
Bill Kirkland, CEO of Collexis. "This past year we have achieved many
milestones in the life sciences and health care markets. As the market leader
in knowledge expert profiles and grant management tools in the sciences,
Collexis is well positioned to become a leading technology solutions provider
in the STM industry for years to come." (For more information about the
Outsell report visit http://outsellinc.com/store/products/772?refid=prcol )
About Outsell, Inc.
Outsell is the only research and advisory firm focused on the publishing,
information, and education industries. Outsell's international team provides
independent, fact-based analysis and actionable advice about competitors,
markets, operational benchmarks, and best practices, so our clients thrive and
grow in today's fast-changing digital and global environment. Outsell's
headquarters are in Burlingame, CA, US and London, UK. For more information,
visit www.outsellinc.com .
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and
knowledge discovery software is headquartered in Columbia, South Carolina
(USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands
and Cologne, Germany. Collexis now offers the world's first pre-populated
scientific social network for life science researchers,
www.biomedexperts.com . Collexis' proprietary technology builds conceptual
profiles of text, called "Fingerprints", from documents, Websites, emails and
other digitized content and matches them with a comprehensive list of
pre-defined "Fingerprinted" concepts to make research results more relevant
and efficient. This matching of concepts eliminates the ambiguity and lack of
priority associated with word searches. The results are often described as
"finding needles in many haystacks." Through this novel approach, Collexis can
build unique applications to search, index and aggregate information as well
as prioritize, trend and predict data based on sources in multiple industries
without the limitations of language or dialect. Collexis' current clients in
the public, private and academic sectors include the Mayo Clinic; Johns
Hopkins University; Dana-Farber Cancer Institute, the University of
California, San Francisco; the University of South Carolina; Erasmus
University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health
Organization; Wellcome Trust; the National Institutes of Health; and the U.S.
Department of Defense. Shares of Collexis common stock are traded under the
symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit
www.collexis.com .
Forward-Looking Statements
Some of the statements made in this press release may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are based on
management's current expectations and include known and unknown risks,
uncertainties and other factors, many of which the company is unable to
predict or control, that may cause the company's actual results or performance
to differ materially from any future results or performance expressed or
implied by such forward-looking statements. These statements involve risks and
uncertainties, including risks and uncertainties. These risks and
uncertainties are in addition to other factors detailed from time to time in
the company's filings with the SEC, including the section entitled "Risk
Factors" in its transition report on Form 10-KSB for the period ended June 30,
2008. The company cautions investors that any forward-looking statements made
by the company are not necessarily indicative of future performance. The
company is not responsible for updating the information contained in this
press release beyond the published date, or for changes made to this document
by wire services or Internet services.
SOURCE Collexis Holdings Inc.